Latest Advances

  • Condition: Femoral Neck Fracture
  • Journal: Acta bio-medica : Atenei Parmensis
  • Treatment Used: Superior Capsular Approach with Hemiarthroplasty Implantation
  • Number of Patients: 50
  • Published —
The study researched the outcome of superior capsular approach with hemiarthroplasty implantation for treating femoral neck fracture.
  • Condition: Cystic Fibrosis
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Vitamin E Supplementation
  • Number of Patients: 141
  • Published —
This review of the literature determined the effects of any level of vitamin E supplementation on the frequency of vitamin E deficiency disorders in people with cystic fibrosis.
  • Condition: Dystonia with Cerebellar Atrophy with Torsion Dystonia of Neck and Cerebellar Ataxia
  • Journal: Rinsho shinkeigaku = Clinical neurology
  • Treatment Used: Pharmacologic Schizophrenia Treatment
  • Number of Patients: 1
  • Published —
This case report describes a 46 year-old suspected of dystonia with marked cerebellar atrophy with torsion dystonia of the neck and cerebellar ataxia that developed during pharmacologic schizophrenia treatment.
  • Condition: Spastic ataxia of Charlevoix-Saguenay
  • Journal: BMC neurology
  • Treatment Used: Docosahexaenoic acid
  • Number of Patients: 2
  • Published —
The study researched the use of docosahexaenoic acid for treating 2 patients with Spastic ataxia of Charlevoix-Saguenay.
  • Condition: Cerebellar Stroke-Like Lesions (SLLs) in Patient with MELAS with m.3243A?>?G Mutation
  • Journal: BMC neurology
  • Treatment Used: Acyclovir, Immunotherapy, Taurine, L-Arginine, Vitamin B1, and Carnitine
  • Number of Patients: 1
  • Published —
This case report describes a 47-year-old Japanese man diagnosed with cerebellar stroke-like lesions (SLLs) in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) with m.3243A?>?G mutation treated with acyclovir, immunotherapy, taurine, l-arginine, Vitamin B1, and carnitine.
  • Condition: Anti-GAD65 Autoimmune Encephalitis
  • Journal: BMC neuroscience
  • Treatment Used: Methylprednisolone Versus Immunoglobulin
  • Number of Patients: 6
  • Published —
In this study, researchers compared the effectiveness of methylprednisolone versus immunoglobulin for the treatment of anti-GAD65 autoimmune encephalitis.
  • Condition: Neurologic syndromes related to anti-GAD65
  • Journal: Neurology(R) neuroimmunology & neuroinflammation
  • Treatment Used: Immunotherapy
  • Number of Patients: 56
  • Published —
This study described clinical and paraclinical characteristics of patients with anti-GAD65 (neurological syndrome) and analyzed their response to immunotherapy.
  • Condition: Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
  • Journal: PloS one
  • Treatment Used: Citicoline
  • Number of Patients: 0
  • Published —
This study tested the safety and efficacy of using citicoline to treat patients with FXTAS.
  • Condition: Cerebellar Ataxia
  • Journal: Journal of neurology, neurosurgery, and psychiatry
  • Treatment Used: Rovatirelin
  • Number of Patients: 411
  • Published —
This study investigated the effectiveness of rovatirelin, a thyrotropin-releasing hormone analogue, for ataxias (nerve degeneration) in patients with spinocerebellar degeneration (SCD).
  • Condition: Cerebellar Ataxia
  • Journal: Physiotherapy research international : the journal for researchers and clinicians in physical therapy
  • Treatment Used: Balance-Based Torso-Weighting
  • Number of Patients: 20
  • Published —
This study tested the safety and efficacy of using a balance-based torso-weighting to improve standing stability in patients with cerebellar ataxia.
  • Condition: Cerebral cysticercosis of the fourth ventricle
  • Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
  • Treatment Used: Microsurgery
  • Number of Patients: 24
  • Published —
The study researched the outcomes of microsurgery in patients with cerebral cysticercosis of the fourth ventricle.
  • Condition: Erdheim-Chester Disease (ECD) Revealed by Diabetes Insipidus
  • Journal: The Pan African medical journal
  • Treatment Used: Pegylated Interferon Alpha
  • Number of Patients: 1
  • Published —
This case report describes a 64-year-old Tunisian female patient diagnosed with Erdheim-Chester disease (abnormal histocytes; ECD) treated with pegylated Interferon alpha.
Showing 1-12 of 29